Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
11.63
-0.58 (-4.75%)
At close: Feb 21, 2025, 4:00 PM
11.75
+0.12 (1.03%)
After-hours: Feb 21, 2025, 7:54 PM EST
Candel Therapeutics Employees
Candel Therapeutics had 42 employees as of December 31, 2023. The number of employees decreased by 34 or -44.74% compared to the previous year.
Employees
42
Change (1Y)
-34
Growth (1Y)
-44.74%
Revenue / Employee
n/a
Profits / Employee
-$1,242,833
Market Cap
493.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 42 | -34 | -44.74% |
Dec 31, 2022 | 76 | 11 | 16.92% |
Dec 31, 2021 | 65 | 24 | 58.54% |
Dec 31, 2020 | 41 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CADL News
- 2 days ago - Candel Therapeutics: Entering Its Pivotal Year - Seeking Alpha
- 5 weeks ago - Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025 - GlobeNewsWire
- 7 weeks ago - Best-Performing Stocks Of 2024 - Seeking Alpha
- 2 months ago - Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 months ago - Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
- 2 months ago - Candel Therapeutics Announces Pricing of Public Offering - GlobeNewsWire
- 2 months ago - Candel Therapeutics Announces $80 Million Proposed Public Offering - GlobeNewsWire
- 2 months ago - Candel Therapeutics: Surprising Win Puts Potential Drug Approval In Sight - Seeking Alpha